Protein kinase C mediates peroxynitrite toxicity to oligodendrocytes

Molecular and Cellular Neuroscience

Volumn 48, Issue 1, 2011, Pages 62-71

  Li, Shihe ^a   Lin, Wen ^a   Tchantchou, Flaubert ^a   Lai, Ruby ^a   Wen, Jie ^a   Zhang, Yumin ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

ERK1 2; Oligodendrocytes; Peroxynitrite; Protein kinase C; Reactive oxygen species; Zinc

Indexed keywords

BISINDOLYLMALEIMIDE; LINSIDOMINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEROXYNITRITE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN KINASE C DELTA; PROTEIN KINASE C GAMMA; REACTIVE OXYGEN METABOLITE; ROTTLERIN;

ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ASSAY; INHIBITION KINETICS; NONHUMAN; OLIGODENDROGLIA; PEROXYNITRITE TOXICITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOXICITY; TOXICOLOGY; WESTERN BLOTTING;

ACETOPHENONES; ANIMALS; BENZOPYRANS; CARBAZOLES; CELLS, CULTURED; CHLORIDES; ENZYME ACTIVATION; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; INDOLES; ISOENZYMES; MALEIMIDES; MOLSIDOMINE; OLIGODENDROGLIA; PEROXYNITROUS ACID; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; ZINC COMPOUNDS;

EID: 79960897851     PISSN: 10447431     EISSN: 10959327     Source Type: Journal    
DOI: 10.1016/j.mcn.2011.06.006     Document Type: Article

References (44)

1. Aras M.A., Hara H., Hartnett K.A., Kandler K., Aizenman E. Protein kinase C regulation of neuronal zinc signaling mediates survival during preconditioning. J. Neurochem. 2009, 110:106-117.
2. Asotra K., Macklin W.B. Protein kinase C activity modulates myelin gene expression in enriched oligodendrocytes. J. Neurosci. Res. 1993, 34:571-588.
3. Asotra K., Macklin W.B. Developmental expression of protein kinase C isozymes in oligodendrocytes and their differential modulation by 4 beta-phorbol-12,13-dibutyrate. J. Neurosci. Res. 1994, 39:273-289.
4. Back S.A., Khan R., Gan X., Rosenberg P.A., Volpe J.J. A new Alamar Blue viability assay to rapidly quantify oligodendrocyte death. J. Neurosci. Meth. 1999, 91:47-54.
5. Baier G., Wagner J. PKC inhibitors: potential in T cell-dependent immune diseases. Curr. Opin. Cell Biol. 2009, 21:262-267.
6. Barnett M.E., Madgwick D.K., Takemoto D.J. Protein kinase C as a stress sensor. Cell Signal. 2007, 19:1820-1829.
7. Baud O., Li J., Zhang Y., Neve R.L., Volpe J.J., Rosenberg P.A. Nitric oxide-induced cell death in developing oligodendrocytes is associated with mitochondrial dysfunction and apoptosis-inducing factor translocation. Eur. J. Neurosci. 2004, 20:1713-1726.
8. Beckman J.S., Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 1996, 271:C1424-C1437.
9. Bhat N.R., Zhang P., Bhat A.N. The expression of myristoylated alanine-rich C-kinase substrate in oligodendrocytes is developmentally regulated. Dev. Neurosci. 1995, 17:256-263.
10. Boschelli D.H. Small molecule inhibitors of PKCTheta as potential antiinflammatory therapeutics. Curr. Top. Med. Chem. 2009, 9:640-654.
11. Calabrese V., Scapagnini G., Ravagna A., Bella R., Foresti R., Bates T.E., Giuffrida Stella A.M., Pennisi G. Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels. J. Neurosci. Res. 2002, 70:580-587.
12. Domenicotti C., Marengo B., Nitti M., Verzola D., Garibotto G., Cottalasso D., Poli G., Melloni E., Pronzato M.A., Marinari U.M. A novel role of protein kinase C-delta in cell signaling triggered by glutathione depletion. Biochem. Pharmacol. 2003, 66:1521-1526.
13. Giorgi C., Agnoletto C., Baldini C., Bononi A., Bonora M., Marchi S., Missiroli S., Patergnani S., Poletti F., Rimessi A., Zavan B., Pinton P. Redox control of protein kinase C: cell- and disease-specific aspects. Antioxid. Redox Signal. 2010, 13:1051-1085.
14. Goekjian P.G., Jirousek M.R. Protein kinase C in the treatment of disease: signal transduction pathways, inhibitors, and agents in development. Curr. Med. Chem. 1999, 6:877-903.
15. Gopalakrishna R., Jaken S. Protein kinase C signaling and oxidative stress. Free Radic. Biol. Med. 2000, 28:1349-1361.
16. Gschwendt M., Muller H.J., Kielbassa K., Zang R., Kittstein W., Rincke G., Marks F. Rottlerin, a novel protein kinase inhibitor. Biochem. Biophys. Res. Commun. 1994, 199:93-98.
17. Hao Q., Maret W. Imbalance between pro-oxidant and pro-antioxidant functions of zinc in disease. J. Alzheimers Dis. 2005, 8:161-170. discussion 209-115.
18. Hayashi K., Altman A. Protein kinase C theta (PKCtheta): a key player in T cell life and death. Pharmacol. Res. 2007, 55:537-544.
19. Howng S.Y., Avila R.L., Emery B., Traka M., Lin W., Watkins T., Cook S., Bronson R., Davisson M., Barres B.A., Popko B. ZFP191 is required by oligodendrocytes for CNS myelination. Genes Dev. 2010, 24:301-311.
20. Kanthasamy A.G., Kitazawa M., Kanthasamy A., Anantharam V. Role of proteolytic activation of protein kinase Cdelta in oxidative stress-induced apoptosis. Antioxid. Redox Signal. 2003, 5:609-620.
21. Koh J.Y. Zinc and disease of the brain. Mol. Neurobiol. 2001, 24:99-106.
22. Leithe E., Cruciani V., Sanner T., Mikalsen S.O., Rivedal E. Recovery of gap junctional intercellular communication after phorbol ester treatment requires proteasomal degradation of protein kinase C. Carcinogenesis 2003, 24:1239-1245.
23. Li J., Baud O., Vartanian T., Volpe J.J., Rosenberg P.A. Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:9936-9941.
24. Majumder P.K., Mishra N.C., Sun X., Bharti A., Kharbanda S., Saxena S., Kufe D. Targeting of protein kinase C delta to mitochondria in the oxidative stress response. Cell Growth Differ. 2001, 12:465-470.
25. Maret W. Metallothionein redox biology in the cytoprotective and cytotoxic functions of zinc. Exp. Gerontol. 2008, 43:363-369.
26. Miller R.L., James-Kracke M., Sun G.Y., Sun A.Y. Oxidative and inflammatory pathways in Parkinson's disease. Neurochem. Res. 2009, 34:55-65.
27. Murriel C.L., Mochly-Rosen D. Opposing roles of delta and epsilonPKC in cardiac ischemia and reperfusion: targeting the apoptotic machinery. Arch. Biochem. Biophys. 2003, 420:246-254.
28. Nelson T.J., Alkon D.L. Neuroprotective versus tumorigenic protein kinase C activators. Trends Biochem. Sci. 2009, 34:136-145.
29. Newton A.C. Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem. J. 2003, 370:361-371.
30. Newton A.C. Protein kinase C: poised to signal. Am. J. Physiol. Endocrinol. Metab. 2010, 298:E395-E402.
31. Noh K.M., Kim Y.H., Koh J.Y. Mediation by membrane protein kinase C of zinc-induced oxidative neuronal injury in mouse cortical cultures. J. Neurochem. 1999, 72:1609-1616.
32. Pacher P., Beckman J.S., Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 2007, 87:315-424.
33. Parekh D.B., Ziegler W., Parker P.J. Multiple pathways control protein kinase C phosphorylation. EMBO J. 2000, 19:496-503.
34. Pleasure D., Soulika A., Singh S.K., Gallo V., Bannerman P. Inflammation in white matter: clinical and pathophysiological aspects. Ment. Retard. Dev. Disabil. Res. Rev. 2006, 12:141-146.
35. Salek-Ardakani S., So T., Halteman B.S., Altman A., Croft M. Protein kinase Ctheta controls Th1 cells in experimental autoimmune encephalomyelitis. J. Immunol. 2005, 175:7635-7641.
36. Shirai Y., Adachi N., Saito N. Protein kinase Cepsilon: function in neurons. FEBS J. 2008, 275:3988-3994.
37. Stabel S., Parker P.J. Protein kinase C. Pharmacol. Ther. 1991, 51:71-95.
38. Steinberg S.F. Structural basis of protein kinase C isoform function. Physiol. Rev. 2008, 88:1341-1378.
39. Tan S.L., Zhao J., Bi C., Chen X.C., Hepburn D.L., Wang J., Sedgwick J.D., Chintalacharuvu S.R., Na S. Resistance to experimental autoimmune encephalomyelitis and impaired IL-17 production in protein kinase C theta-deficient mice. J. Immunol. 2006, 176:2872-2879.
40. Wang H., Li J., Follett P.L., Zhang Y., Cotanche D.A., Jensen F.E., Volpe J.J., Rosenberg P.A. 12-Lipoxygenase plays a key role in cell death caused by glutathione depletion and arachidonic acid in rat oligodendrocytes. Eur. J. Neurosci. 2004, 20:2049-2058.
41. Xie Z., Wei M., Morgan T.E., Fabrizio P., Han D., Finch C.E., Longo V.D. Peroxynitrite mediates neurotoxicity of amyloid beta-peptide1-42- and lipopolysaccharide-activated microglia. J. Neurosci. 2002, 22:3484-3492.
42. Zhang Y., Rosenberg P.A. Caspase-1 and poly (ADP-ribose) polymerase inhibitors may protect against peroxynitrite-induced neurotoxicity independent of their enzyme inhibitor activity. Eur. J. Neurosci. 2004, 20:1727-1736.
43. Zhang Y., Wang H., Li J., Dong L., Xu P., Chen W., Neve R.L., Volpe J.J., Rosenberg P.A. Intracellular zinc release and ERK phosphorylation are required upstream of 12-lipoxygenase activation in peroxynitrite toxicity to mature rat oligodendrocytes. J. Biol. Chem. 2006, 281:9460-9470.
44. Zhang Y., Aizenman E., DeFranco D.B., Rosenberg P.A. Intracellular zinc release, 12-lipoxygenase activation and MAPK dependent neuronal and oligodendroglial death. Mol. Med. 2007, 13:350-355.